These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34753634)

  • 1. Impact of OMNIPOD® on the quality of life of adolescents with type 1 diabetes.
    Nivet E; Lo G; Nivot-Adamiak S; Guitteny MA; De Kerdanet M
    Arch Pediatr; 2022 Jan; 29(1):21-26. PubMed ID: 34753634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Satisfaction With Omnipod DASH in Adults With Type 1 Diabetes: A Nonblinded 1:1 Randomized Controlled Trial.
    Kong YW; Yuan CY; Kiburg K; Brown K; Trawley S; Partovi A; Roem K; Pham C; Harrison N; Fourlanos S; Ekinci EI; O'Neal DN
    J Clin Endocrinol Metab; 2024 Jul; 109(8):1984-1995. PubMed ID: 38373265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Omnipod
    Polonsky WH; Hessler D; Layne JE; Zisser H
    Diabetes Technol Ther; 2016 Oct; 18(10):664-670. PubMed ID: 27673352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing Insulin Pump Devices in Real Life: The AWeSoMe Study Group Prospective Experience.
    Rachmiel M; Levy-Shraga Y; Gruber N; Pinhas-Hamiel O; Barash G; Pivko-Levy D; Landau Z
    Diabetes Technol Ther; 2019 Mar; 21(3):138-145. PubMed ID: 30702335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Feasibility of the OmniPod Hybrid Closed-Loop System in Adult, Adolescent, and Pediatric Patients with Type 1 Diabetes Using a Personalized Model Predictive Control Algorithm.
    Buckingham BA; Forlenza GP; Pinsker JE; Christiansen MP; Wadwa RP; Schneider J; Peyser TA; Dassau E; Lee JB; O'Connor J; Layne JE; Ly TT
    Diabetes Technol Ther; 2018 Apr; 20(4):257-262. PubMed ID: 29431513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of the Omnipod Insulin Management System on Glycemic Control in Patients With Type 1 Diabetes Previously Treated With Multiple Daily Injections or Continuous Subcutaneous Insulin Infusion.
    Layne JE; Parkin CG; Zisser H
    J Diabetes Sci Technol; 2016 Sep; 10(5):1130-5. PubMed ID: 27290737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient perceptions of using the OmniPod system compared with conventional insulin pumps in young adults with type 1 diabetes.
    Lebenthal Y; Lazar L; Benzaquen H; Shalitin S; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):411-7. PubMed ID: 22283640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry.
    Danne T; Schwandt A; Biester T; Heidtmann B; Rami-Merhar B; Haberland H; Müther S; Khodaverdi S; Haak T; Holl RW;
    Pediatr Diabetes; 2018 Aug; 19(5):979-984. PubMed ID: 29446511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin Pump Therapy in Adolescents With Very Poor Glycemic Control During a 12-Month Cohort Trial.
    de Bock M; Rossborough J; Siafarikas A; Evans M; Clapin H; Smith G; Jones T; Davis E
    J Diabetes Sci Technol; 2018 Sep; 12(5):1080-1081. PubMed ID: 29619896
    [No Abstract]   [Full Text] [Related]  

  • 10. Real-world outcomes of Omnipod DASH system use in people with type 1 diabetes: Evidence from the Association of British Clinical Diabetologists (ABCD) study.
    Liarakos AL; Hasan N; Crabtree TSJ; Leelarathna L; Hammond P; Hussain S; Haq M; Aslam A; Gatdula E; Gibb FW; Lumb A; Bull K; Chinnasamy E; Carrieri G; Williams DM; Choudhary P; Ryder REJ; Wilmot EG
    Diabetes Res Clin Pract; 2024 Mar; 209():111597. PubMed ID: 38417535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion attenuated glycemic instability in preschool children with type 1 diabetes mellitus.
    Alemzadeh R; Palma-Sisto P; Holzum M; Parton E; Kicher J
    Diabetes Technol Ther; 2007 Aug; 9(4):339-47. PubMed ID: 17705689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
    Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
    Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin regimens, diabetes knowledge, quality of life, and HbA1c in children and adolescents with type 1 diabetes.
    Keller M; Attia R; Beltrand J; Djadi-Prat J; Nguyen-Khoa T; Jay JP; Cahané M; Choleau C; Robert JJ
    Pediatr Diabetes; 2017 Aug; 18(5):340-347. PubMed ID: 27161814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Performance of the Omnipod Hybrid Closed-Loop System in Adults, Adolescents, and Children with Type 1 Diabetes Over 5 Days Under Free-Living Conditions.
    Sherr JL; Buckingham BA; Forlenza GP; Galderisi A; Ekhlaspour L; Wadwa RP; Carria L; Hsu L; Berget C; Peyser TA; Lee JB; O'Connor J; Dumais B; Huyett LM; Layne JE; Ly TT
    Diabetes Technol Ther; 2020 Mar; 22(3):174-184. PubMed ID: 31596130
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age.
    Ly TT; Layne JE; Huyett LM; Nazzaro D; O'Connor JB
    J Diabetes Sci Technol; 2019 Jan; 13(1):20-26. PubMed ID: 30239214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of depressive symptoms in well-controlled adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion.
    Zduńczyk B; Sendela J; Szypowska A
    Diabetes Metab Res Rev; 2014 May; 30(4):333-8. PubMed ID: 24323887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R; Palma-Sisto P; Parton EA; Holzum MK
    Diabetes Technol Ther; 2005 Aug; 7(4):587-96. PubMed ID: 16120030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How introduction of automated insulin delivery systems may influence psychosocial outcomes in adults with type 1 diabetes: Findings from the first investigation with the Omnipod® 5 System.
    Polonsky WH; Hood KK; Levy CJ; MacLeish SA; Hirsch IB; Brown SA; Bode BW; Carlson AL; Shah VN; Weinstock RS; Bhargava A; Jones TC; Aleppo G; Mehta SN; Laffel LM; Forlenza GP; Sherr JL; Huyett LM; Vienneau TE; Ly TT;
    Diabetes Res Clin Pract; 2022 Aug; 190():109998. PubMed ID: 35853530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
    Nixon R; Pickup JC
    Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.